<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00427895</url>
  </required_header>
  <id_info>
    <org_study_id>6115A1-004</org_study_id>
    <secondary_id>B1851019</secondary_id>
    <nct_id>NCT00427895</nct_id>
    <nct_alias>NCT00488852</nct_alias>
    <nct_alias>NCT00774410</nct_alias>
  </id_info>
  <brief_title>Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults</brief_title>
  <official_title>A Phase 3, Randomized, Active-Controlled, Modified Double-blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine (13vPnC) Compared to a 23-valent Pneumococcal Polysaccharide Vaccine (23vPS) in Adults 60 to 64 Years Old Who Are Naive to 23vPS and the Safety, Tolerability, and Immunogenicity of 13vPnC in Adults 18 to 59 Years Old Who Are Naïve to 23vPS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the safety, tolerability and immune response of 13-valent pneumococcal
      conjugate vaccine (13vPnC) compared with 23-valent Pneumococcal Polysaccharide Vaccine
      (23vPS). Although the study started with only 1 population, amendments to the original
      protocol will now reflect three participant populations. Three age cohorts will be enrolled.
      The first cohort (age 60-64) will be blinded. Cohort 2 (age 50-59) and cohort 3 (age 18-49)
      are open label. Subjects in cohorts 1 and 2 will receive 2 vaccinations 3-4 years apart.
      Subjects in cohort 3 will receive 1 vaccination. All participants should be naïve of 23vPS.
      Comparisons of immune responses from the different cohorts will be done.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination 1</measure>
    <time_frame>One month after vaccination 1</time_frame>
    <description>Serotype-specific OPA GMTs for the 13 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using microcolony OPA (mcOPA) assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Achieving At Least a 4-fold Rise in OPA Titer for Serotype 6A 1 Month After Vaccination 1 in Cohort 1</measure>
    <time_frame>One month after vaccination 1</time_frame>
    <description>For serotype 6A the percentage of participants achieving at least a 4-fold rise on the serotype-specific antibody titer from pre-vaccination to 1 month post-vaccination was computed along with exact, 2-sided 95% confidence interval for the proportion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS Group and 23vPS/23vPS Group</measure>
    <time_frame>One month after vaccination 1 and One month after vaccination 2/Year 3 to 4</time_frame>
    <description>Serotype-specific OPA GMTs for the 12 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using mcOPA assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving OPA Titers With at Least Lower Limit of Quantification (LLOQ) 1 Month After Vaccination 1</measure>
    <time_frame>One month after vaccination 1</time_frame>
    <description>Percentage of participants achieving OPA GMTs with at least LLOQ for 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) determined in blood samples of all participants using mcOPA assay. Exact 2-sided CI based on observed proportion of participants. LLOQ for each serotype: 1=1:18, 3=1:12, 4=1:21, 5=1:29, 6A=1:37, 6B=1:43, 7F=1:210, 9V=1:345, 14=1:35, 18C=1:31, 19A=1:18, 19F=1:48, 23F=1:13.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) for the 13 Serotypes From Prevaccination 1 to 1 Month After Vaccination 2 in Cohort 1 and Cohort 2</measure>
    <time_frame>Prevaccination 1 to 1 month after vaccination 2/Year 3 to 4</time_frame>
    <description>Geometric mean fold rises (GMFRs) for the 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) from prevaccination to 1 month postvaccination were computed using the logarithmically transformed assay results. CI for the GMFRs are back transformations of a CI based on the Student t distribution for the logarithmically transformed assay results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMC) for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS and 23vPS/23vPS Groups in Cohort 1; and in 13vPnC/13vPnC Group in Cohort 2, 1 Month After Vaccination</measure>
    <time_frame>One month after vaccination 1 and One month after vaccination 2/Year 3 to 4</time_frame>
    <description>Antibody geometric mean concentration (GMC) as measured by microgram/milliliter (mcg/mL) for 12 common pneumococcal serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) are presented. GMC and corresponding 2-sided 95% confidence intervals (CI) were evaluated. Geometric means (GMs) were calculated using all participants with available data for the specified blood draw.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1</time_frame>
    <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 centimeters [cm]; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation [lim] present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</measure>
    <time_frame>Within 14 days after vaccination 2</time_frame>
    <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 cm; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 1</measure>
    <time_frame>Within 14 days after vaccination 1</time_frame>
    <description>Systemic events reported using an electronic diary. Systemic events are any fever greater than or equal to (&gt;=) 38 degrees Celsius [C], fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized (gen) muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain. All reports of fever &gt;40 degrees C in 13vPnC and 23vPS for Cohort 1 were confirmed as data entry errors.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</measure>
    <time_frame>Within 14 days after vaccination 2</time_frame>
    <description>Systemic events reported using an electronic diary. Systemic events are any fever &gt;=38 degrees C, fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain.</description>
  </other_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">2141</enrollment>
  <condition>Pneumococcal Infections</condition>
  <arm_group>
    <arm_group_label>13vPnC Cohort 1, Vaccination 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants aged 60-64 years were given a 0.5 mL dose administered on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>23vPS Cohort 1, Vaccination 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants aged 60-64 years were given a 0.5 mL dose administered on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>13vPnC Cohort 2, Vaccination 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants aged 50-59 years given a 0.5 mL dose administered on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>13vPnC Cohort 3, Vaccination 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants aged 18-49 years given a 0.5 mL dose administered on day 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>13vPnC Cohort 1, Vaccination 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants aged 60-64 years who received 13vPnC at vaccination 1 receive a 0.5 mL dose of 13vPnC administered 3-4 years after dose 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>23vPS Cohort 1, Vaccination 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants aged 60-64 years who received 23vPS at vaccination 1 receive a 0.5 mL dose of 23vPS administered 3-4 years after dose 1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>13vPnC Cohort 2, Vaccination 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants aged 50-59 years who received 13vPnC at vaccination 1 receive a 0.5 mL dose of 13vPnC administered 3-4 years after dose 1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine (13vPnC)</intervention_name>
    <description>0.5 mL dose administered on day 1</description>
    <arm_group_label>13vPnC Cohort 1, Vaccination 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>23-valent Pneumococcal Polysaccharide Vaccine (23vPS)</intervention_name>
    <description>0.5 mL dose administered on day 1</description>
    <arm_group_label>23vPS Cohort 1, Vaccination 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine (13vPnC)</intervention_name>
    <description>0.5 mL dose administered on day 1</description>
    <arm_group_label>13vPnC Cohort 2, Vaccination 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine (13vPnC)</intervention_name>
    <description>0.5 mL dose administered on day 1</description>
    <arm_group_label>13vPnC Cohort 3, Vaccination 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine (13vPnC)</intervention_name>
    <description>0.5 mL dose administered 3-4 years after dose 1</description>
    <arm_group_label>13vPnC Cohort 1, Vaccination 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>23-valent Pneumococcal Polysaccharide Vaccine (23vPS)</intervention_name>
    <description>0.5 mL dose administered 3-4 years after dose 1</description>
    <arm_group_label>23vPS Cohort 1, Vaccination 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13-valent pneumococcal conjugate vaccine (13vPnC)</intervention_name>
    <description>0.5 mL dose administered 3-4 years after dose 1</description>
    <arm_group_label>13vPnC Cohort 2, Vaccination 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First Cohort: Healthy Male and female adults 60 to 64 years of age at time of
             enrollment.

          -  Second Cohort: Healthy Male and female adults 50 to 59 years of age at time of
             enrollment.

          -  Third Cohort: Healthy Male and female adults 18 to 49 years of age at time of
             enrollment.

        Exclusion Criteria:

          -  Previous immunization with any licensed or experimental pneumococcal vaccine.

          -  Serious chronic disorders including metastatic malignancy, severe chronic obstructive
             pulmonary disease (COPD) requiring supplemental oxygen, end stage renal disease with
             or without dialysis, clinically unstable cardiac disease, or any other disorder which
             in the investigator's opinion precludes the subject from participating in the study.

          -  Known or suspected impairment of immunological function.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35802</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Chandler</city>
        <state>Arizona</state>
        <zip>85224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Pembroke Pines</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <zip>83642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>South Bend</city>
        <state>Indiana</state>
        <zip>46601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Bardstown</city>
        <state>Kentucky</state>
        <zip>40004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>275188</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Upper St. Clair</city>
        <state>Pennsylvania</state>
        <zip>15241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02886</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Bristol</city>
        <state>Tennessee</state>
        <zip>37620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>West Jordan</city>
        <state>Utah</state>
        <zip>84088</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pfizer Investigational Site</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=6115A1-004&amp;StudyName=Study%20Comparing%20a%2013-valent%20Pneumococcal%20Conjugate%20Vaccine%20With%2023-valent%20Pneumococcal%20Polysaccharide%20Vaccine%20in%20Adults</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2007</study_first_submitted>
  <study_first_submitted_qc>January 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2007</study_first_posted>
  <results_first_submitted>August 1, 2012</results_first_submitted>
  <results_first_submitted_qc>August 1, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 5, 2012</results_first_posted>
  <last_update_submitted>August 1, 2012</last_update_submitted>
  <last_update_submitted_qc>August 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vaccine</keyword>
  <keyword>Pneumococcal Infections Prevention and Control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Participants in Cohort 1 and 2 participated for 1 year in the study. Vaccination 2 (3 to 4 years after vaccination 1) was administered to participants in Cohort 1 and 2. Participants in Cohort 3 enrolled as part of amendment 3 participated for 6 months and participants in Cohort 3 enrolled as part of amendment 4 participated for 1 year in study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>13vPnC, Cohort 1</title>
          <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]) at baseline.</description>
        </group>
        <group group_id="P2">
          <title>23vPS, Cohort 1</title>
          <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1) at baseline.</description>
        </group>
        <group group_id="P3">
          <title>13vPnC, Cohort 2</title>
          <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly at (Vaccination 1) at baseline.</description>
        </group>
        <group group_id="P4">
          <title>13vPnC, Cohort 3</title>
          <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1) at baseline.</description>
        </group>
        <group group_id="P5">
          <title>13vPnC/13vPnC, Cohort 1</title>
          <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received open-label 0.5 mL single dose intramuscularly of 13vPnC (Vaccination 2) at Year 3 to 4.</description>
        </group>
        <group group_id="P6">
          <title>13vPnC/23vPS, Cohort 1</title>
          <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received open-label 0.5 mL single dose intramuscularly of 23vPS (Vaccination 2) at Year 3 to 4.</description>
        </group>
        <group group_id="P7">
          <title>23vPS/23vPS, Cohort 1</title>
          <description>Participants 60-64 years of age who received 23vPS at vaccination 1, received open-label 0.5 mL single dose intramuscularly of 23vPS (Vaccination 2) at Year 3 to 4.</description>
        </group>
        <group group_id="P8">
          <title>13vPnC/13vPnC, Cohort 2</title>
          <description>Participants 50-59 years of age who received 13vPnC at vaccination 1, received open-label 0.5 mL single dose intramuscularly of 13vPnC (Vaccination 2) at Year 3 to 4.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Vax 1 Baseline/6-Month Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="418"/>
                <participants group_id="P2" count="417"/>
                <participants group_id="P3" count="406"/>
                <participants group_id="P4" count="900"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated</title>
              <participants_list>
                <participants group_id="P1" count="417"/>
                <participants group_id="P2" count="414"/>
                <participants group_id="P3" count="404"/>
                <participants group_id="P4" count="899"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="411"/>
                <participants group_id="P2" count="411"/>
                <participants group_id="P3" count="392"/>
                <participants group_id="P4" count="854"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="14"/>
                <participants group_id="P4" count="46"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="32"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="7"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to Return</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Randomized, Not Vaccinated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Between 6-Month Follow-up - Year 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="411"/>
                <participants group_id="P2" count="411"/>
                <participants group_id="P3" count="392"/>
                <participants group_id="P4" count="854"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="411"/>
                <participants group_id="P2" count="411"/>
                <participants group_id="P3" count="392"/>
                <participants group_id="P4" count="502"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="352"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did not enter 1-year blood draw</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="352"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Vax 1/Year 1 Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="411"/>
                <participants group_id="P2" count="411"/>
                <participants group_id="P3" count="392"/>
                <participants group_id="P4" count="502"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="404"/>
                <participants group_id="P2" count="396"/>
                <participants group_id="P3" count="373"/>
                <participants group_id="P4" count="469"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="19"/>
                <participants group_id="P4" count="33"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="21"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="4"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to Return</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Between Year 1 - Vax 2/Year 3 to 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="404"/>
                <participants group_id="P2" count="396"/>
                <participants group_id="P3" count="373"/>
                <participants group_id="P4" count="469"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="216"/>
                <participants group_id="P2" count="189"/>
                <participants group_id="P3" count="214"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="188"/>
                <participants group_id="P2" count="207"/>
                <participants group_id="P3" count="159"/>
                <participants group_id="P4" count="469"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Did Not Consent to Receive Vax 2</title>
              <participants_list>
                <participants group_id="P1" count="188"/>
                <participants group_id="P2" count="207"/>
                <participants group_id="P3" count="159"/>
                <participants group_id="P4" count="469"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Vax 2/Year 3 to 4</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="108"/>
                <participants group_id="P6" count="108"/>
                <participants group_id="P7" count="189"/>
                <participants group_id="P8" count="214"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="107"/>
                <participants group_id="P6" count="108"/>
                <participants group_id="P7" count="189"/>
                <participants group_id="P8" count="212"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to Return</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>13vPnC, Cohort 1</title>
          <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]).</description>
        </group>
        <group group_id="B2">
          <title>23vPS, Cohort 1</title>
          <description>Participants aged 60-64 years old received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
        </group>
        <group group_id="B3">
          <title>13vPnC, Cohort 2</title>
          <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
        </group>
        <group group_id="B4">
          <title>13vPnC, Cohort 3</title>
          <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="417"/>
            <count group_id="B2" value="414"/>
            <count group_id="B3" value="403"/>
            <count group_id="B4" value="899"/>
            <count group_id="B5" value="2133"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18 to 29 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="300"/>
                    <measurement group_id="B5" value="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 to 39 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="298"/>
                    <measurement group_id="B5" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>40 to 49 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="301"/>
                    <measurement group_id="B5" value="301"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>50 to 59 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="403"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="403"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60 to 64 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="417"/>
                    <measurement group_id="B2" value="414"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="831"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>In 13vPnc, Cohort 2; out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence baseline characteristics are available for 403 participant.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                    <measurement group_id="B2" value="252"/>
                    <measurement group_id="B3" value="249"/>
                    <measurement group_id="B4" value="523"/>
                    <measurement group_id="B5" value="1247"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="194"/>
                    <measurement group_id="B2" value="162"/>
                    <measurement group_id="B3" value="154"/>
                    <measurement group_id="B4" value="376"/>
                    <measurement group_id="B5" value="886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination 1</title>
        <description>Serotype-specific OPA GMTs for the 13 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using microcolony OPA (mcOPA) assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
        <time_frame>One month after vaccination 1</time_frame>
        <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]).</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
          <group group_id="O3">
            <title>13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly at (Vaccination 1).</description>
          </group>
          <group group_id="O4">
            <title>13vPnC, Cohort 3</title>
            <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
        </group_list>
        <measure>
          <title>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination 1</title>
          <description>Serotype-specific OPA GMTs for the 13 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using microcolony OPA (mcOPA) assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
          <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="411"/>
                <count group_id="O2" value="407"/>
                <count group_id="O3" value="388"/>
                <count group_id="O4" value="874"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 (n= 404, 402, 382, 866)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="146" lower_limit="124.0" upper_limit="172.9"/>
                    <measurement group_id="O2" value="104" lower_limit="87.7" upper_limit="124.4"/>
                    <measurement group_id="O3" value="200" lower_limit="170.3" upper_limit="236.0"/>
                    <measurement group_id="O4" value="353" lower_limit="322.8" upper_limit="386.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 (n= 394, 401, 379, 860)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93" lower_limit="81.1" upper_limit="106.6"/>
                    <measurement group_id="O2" value="85" lower_limit="74.2" upper_limit="98.3"/>
                    <measurement group_id="O3" value="91" lower_limit="79.9" upper_limit="104.7"/>
                    <measurement group_id="O4" value="91" lower_limit="84.2" upper_limit="98.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 (n= 359, 367, 350, 849)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2062" lower_limit="1693.6" upper_limit="2510.5"/>
                    <measurement group_id="O2" value="1295" lower_limit="1045.9" upper_limit="1603.0"/>
                    <measurement group_id="O3" value="2833" lower_limit="2412.1" upper_limit="3327.4"/>
                    <measurement group_id="O4" value="4747" lower_limit="4370.2" upper_limit="5155.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 (n= 392, 393, 373, 836)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="199" lower_limit="164.0" upper_limit="242.3"/>
                    <measurement group_id="O2" value="162" lower_limit="133.6" upper_limit="197.5"/>
                    <measurement group_id="O3" value="269" lower_limit="218.1" upper_limit="332.5"/>
                    <measurement group_id="O4" value="386" lower_limit="342.6" upper_limit="435.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6A (n= 401, 392, 384, 855)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2593" lower_limit="2146.7" upper_limit="3131.1"/>
                    <measurement group_id="O2" value="213" lower_limit="160.3" upper_limit="284.3"/>
                    <measurement group_id="O3" value="4328" lower_limit="3658.1" upper_limit="5121.5"/>
                    <measurement group_id="O4" value="5746" lower_limit="5240.7" upper_limit="6300.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6B (n= 371, 371, 361, 865)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1984" lower_limit="1604.0" upper_limit="2453.6"/>
                    <measurement group_id="O2" value="788" lower_limit="615.9" upper_limit="1008.5"/>
                    <measurement group_id="O3" value="3212" lower_limit="2728.6" upper_limit="3781.4"/>
                    <measurement group_id="O4" value="9813" lower_limit="9097.8" upper_limit="10583.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7F (n= 394, 396, 378, 859)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1120" lower_limit="907.6" upper_limit="1382.9"/>
                    <measurement group_id="O2" value="405" lower_limit="311.9" upper_limit="524.7"/>
                    <measurement group_id="O3" value="1520" lower_limit="1274.5" upper_limit="1812.1"/>
                    <measurement group_id="O4" value="3249" lower_limit="2994.8" upper_limit="3523.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9V (n= 367, 368, 364, 844)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1164" lower_limit="934.8" upper_limit="1448.3"/>
                    <measurement group_id="O2" value="407" lower_limit="307.2" upper_limit="539.8"/>
                    <measurement group_id="O3" value="1726" lower_limit="1428.5" upper_limit="2086.2"/>
                    <measurement group_id="O4" value="3339" lower_limit="3037.4" upper_limit="3670.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 (n= 375, 378, 373, 860)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="612" lower_limit="489.6" upper_limit="764.2"/>
                    <measurement group_id="O2" value="692" lower_limit="553.3" upper_limit="866.2"/>
                    <measurement group_id="O3" value="957" lower_limit="779.6" upper_limit="1174.5"/>
                    <measurement group_id="O4" value="2983" lower_limit="2740.5" upper_limit="3246.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18C (n= 379, 381, 373, 850)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1726" lower_limit="1429.7" upper_limit="2082.9"/>
                    <measurement group_id="O2" value="925" lower_limit="735.3" upper_limit="1162.9"/>
                    <measurement group_id="O3" value="1939" lower_limit="1599.2" upper_limit="2350.2"/>
                    <measurement group_id="O4" value="3989" lower_limit="3629.4" upper_limit="4383.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19A (n= 392, 388, 377, 855)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="682" lower_limit="596.5" upper_limit="779.9"/>
                    <measurement group_id="O2" value="352" lower_limit="297.0" upper_limit="416.1"/>
                    <measurement group_id="O3" value="956" lower_limit="837.6" upper_limit="1090.7"/>
                    <measurement group_id="O4" value="1580" lower_limit="1471.4" upper_limit="1696.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19F (n= 377, 370, 367, 841)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="517" lower_limit="420.8" upper_limit="635.3"/>
                    <measurement group_id="O2" value="539" lower_limit="442.1" upper_limit="658.2"/>
                    <measurement group_id="O3" value="599" lower_limit="491.0" upper_limit="731.0"/>
                    <measurement group_id="O4" value="1533" lower_limit="1397.3" upper_limit="1680.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23F (n= 375, 375, 368, 851)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="375" lower_limit="297.2" upper_limit="472.6"/>
                    <measurement group_id="O2" value="72" lower_limit="55.9" upper_limit="93.4"/>
                    <measurement group_id="O3" value="494" lower_limit="386.8" upper_limit="630.7"/>
                    <measurement group_id="O4" value="1570" lower_limit="1392.8" upper_limit="1770.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.10</ci_lower_limit>
            <ci_upper_limit>1.78</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.32</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.19</ci_lower_limit>
            <ci_upper_limit>2.13</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.93</ci_lower_limit>
            <ci_upper_limit>1.62</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>12.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>8.63</ci_lower_limit>
            <ci_upper_limit>17.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.82</ci_lower_limit>
            <ci_upper_limit>3.48</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.98</ci_lower_limit>
            <ci_upper_limit>3.87</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.00</ci_lower_limit>
            <ci_upper_limit>4.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.64</ci_lower_limit>
            <ci_upper_limit>1.21</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.39</ci_lower_limit>
            <ci_upper_limit>2.51</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.56</ci_lower_limit>
            <ci_upper_limit>2.41</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>1.28</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC – 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>5.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.67</ci_lower_limit>
            <ci_upper_limit>7.33</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.08</ci_lower_limit>
            <ci_upper_limit>1.73</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.19</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.07</ci_lower_limit>
            <ci_upper_limit>1.77</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.01</ci_lower_limit>
            <ci_upper_limit>1.80</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.30</ci_lower_limit>
            <ci_upper_limit>2.15</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.24</ci_lower_limit>
            <ci_upper_limit>2.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.03</ci_lower_limit>
            <ci_upper_limit>1.79</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.11</ci_lower_limit>
            <ci_upper_limit>1.98</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.16</ci_lower_limit>
            <ci_upper_limit>2.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.86</ci_lower_limit>
            <ci_upper_limit>1.47</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.16</ci_lower_limit>
            <ci_upper_limit>1.69</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.54</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 2.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.84</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.03</ci_lower_limit>
            <ci_upper_limit>2.87</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.84</ci_lower_limit>
            <ci_upper_limit>1.13</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.92</ci_lower_limit>
            <ci_upper_limit>2.76</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.55</ci_lower_limit>
            <ci_upper_limit>2.42</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.84</ci_lower_limit>
            <ci_upper_limit>2.67</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.13</ci_lower_limit>
            <ci_upper_limit>5.93</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.41</ci_lower_limit>
            <ci_upper_limit>3.49</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.34</ci_lower_limit>
            <ci_upper_limit>3.52</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.01</ci_lower_limit>
            <ci_upper_limit>5.93</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.91</ci_lower_limit>
            <ci_upper_limit>2.79</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.02</ci_lower_limit>
            <ci_upper_limit>2.66</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.44</ci_lower_limit>
            <ci_upper_limit>3.60</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures in 13vPnC participants between Cohort 1 and Cohort 3.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.31</ci_lower_limit>
            <ci_upper_limit>5.31</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Achieving At Least a 4-fold Rise in OPA Titer for Serotype 6A 1 Month After Vaccination 1 in Cohort 1</title>
        <description>For serotype 6A the percentage of participants achieving at least a 4-fold rise on the serotype-specific antibody titer from pre-vaccination to 1 month post-vaccination was computed along with exact, 2-sided 95% confidence interval for the proportion.</description>
        <time_frame>One month after vaccination 1</time_frame>
        <population>Evaluable immunogenicity population; N (number of participants analyzed) signifies participants with determinate OPA antibody titer to serotype 6A.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]).</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving At Least a 4-fold Rise in OPA Titer for Serotype 6A 1 Month After Vaccination 1 in Cohort 1</title>
          <description>For serotype 6A the percentage of participants achieving at least a 4-fold rise on the serotype-specific antibody titer from pre-vaccination to 1 month post-vaccination was computed along with exact, 2-sided 95% confidence interval for the proportion.</description>
          <population>Evaluable immunogenicity population; N (number of participants analyzed) signifies participants with determinate OPA antibody titer to serotype 6A.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="374"/>
                <count group_id="O2" value="377"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.5" lower_limit="84.8" upper_limit="91.6"/>
                    <measurement group_id="O2" value="49.3" lower_limit="44.2" upper_limit="54.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>39.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>33.0</ci_lower_limit>
            <ci_upper_limit>45.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS Group and 23vPS/23vPS Group</title>
        <description>Serotype-specific OPA GMTs for the 12 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using mcOPA assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
        <time_frame>One month after vaccination 1 and One month after vaccination 2/Year 3 to 4</time_frame>
        <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
          <group group_id="O3">
            <title>23vPs/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 23vPS at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) 1 Month After Vaccination for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS Group and 23vPS/23vPS Group</title>
          <description>Serotype-specific OPA GMTs for the 12 pneumococcal common serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) were determined in the blood samples of all the participants using mcOPA assay. CIs for GMT are back transformations of a CI based on the Student t distribution for the mean logarithm of the titers.</description>
          <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
          <units>titers</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="407"/>
                <count group_id="O3" value="189"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 (n= 105, 184, 186)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="398" lower_limit="306.2" upper_limit="516.3"/>
                    <measurement group_id="O2" value="116" lower_limit="89.4" upper_limit="149.6"/>
                    <measurement group_id="O3" value="95" lower_limit="74.8" upper_limit="121.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 (n= 107, 184, 181)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164" lower_limit="129.0" upper_limit="207.5"/>
                    <measurement group_id="O2" value="105" lower_limit="85.3" upper_limit="128.7"/>
                    <measurement group_id="O3" value="53" lower_limit="42.8" upper_limit="64.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 (n= 107, 174, 174)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1875" lower_limit="1488.8" upper_limit="2360.7"/>
                    <measurement group_id="O2" value="1420" lower_limit="1066.2" upper_limit="1890.5"/>
                    <measurement group_id="O3" value="733" lower_limit="555.1" upper_limit="968.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 (n= 106, 181, 180)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="476" lower_limit="356.2" upper_limit="636.1"/>
                    <measurement group_id="O2" value="149" lower_limit="111.1" upper_limit="201.2"/>
                    <measurement group_id="O3" value="74" lower_limit="54.2" upper_limit="100.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6B (n= 104, 174, 181)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2670" lower_limit="2012.9" upper_limit="3540.6"/>
                    <measurement group_id="O2" value="1088" lower_limit="774.7" upper_limit="1528.1"/>
                    <measurement group_id="O3" value="916" lower_limit="670.0" upper_limit="1252.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7F (n= 105, 181, 182)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1895" lower_limit="1471.0" upper_limit="2441.1"/>
                    <measurement group_id="O2" value="403" lower_limit="276.3" upper_limit="588.9"/>
                    <measurement group_id="O3" value="497" lower_limit="361.8" upper_limit="682.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9V (n= 107, 167, 177)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1089" lower_limit="699.2" upper_limit="1695.0"/>
                    <measurement group_id="O2" value="654" lower_limit="452.5" upper_limit="944.9"/>
                    <measurement group_id="O3" value="187" lower_limit="125.0" upper_limit="280.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 (n= 105, 173, 180)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1268" lower_limit="951.8" upper_limit="1690.0"/>
                    <measurement group_id="O2" value="824" lower_limit="612.9" upper_limit="1107.8"/>
                    <measurement group_id="O3" value="661" lower_limit="515.6" upper_limit="848.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18C (n= 103, 174, 180)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2489" lower_limit="1941.1" upper_limit="3192.7"/>
                    <measurement group_id="O2" value="1135" lower_limit="815.7" upper_limit="1578.6"/>
                    <measurement group_id="O3" value="802" lower_limit="597.5" upper_limit="1076.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19A (n= 106, 182, 184)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="966" lower_limit="763.2" upper_limit="1223.6"/>
                    <measurement group_id="O2" value="377" lower_limit="296.1" upper_limit="479.6"/>
                    <measurement group_id="O3" value="364" lower_limit="290.0" upper_limit="458.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19F (n= 99, 170, 176)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1653" lower_limit="1302.2" upper_limit="2099.5"/>
                    <measurement group_id="O2" value="621" lower_limit="468.6" upper_limit="821.7"/>
                    <measurement group_id="O3" value="374" lower_limit="286.1" upper_limit="488.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23F (n= 105, 173, 181)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="299" lower_limit="203.9" upper_limit="437.5"/>
                    <measurement group_id="O2" value="86" lower_limit="58.8" upper_limit="124.5"/>
                    <measurement group_id="O3" value="54" lower_limit="38.4" upper_limit="77.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.32</ci_lower_limit>
            <ci_upper_limit>5.09</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.13</ci_lower_limit>
            <ci_upper_limit>2.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.88</ci_lower_limit>
            <ci_upper_limit>1.98</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.04</ci_lower_limit>
            <ci_upper_limit>4.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.50</ci_lower_limit>
            <ci_upper_limit>4.00</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.76</ci_lower_limit>
            <ci_upper_limit>7.99</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.93</ci_lower_limit>
            <ci_upper_limit>2.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.99</ci_lower_limit>
            <ci_upper_limit>2.39</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.37</ci_lower_limit>
            <ci_upper_limit>3.50</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.78</ci_lower_limit>
            <ci_upper_limit>3.68</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.77</ci_lower_limit>
            <ci_upper_limit>4.01</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.99</ci_lower_limit>
            <ci_upper_limit>6.13</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.87</ci_lower_limit>
            <ci_upper_limit>6.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.26</ci_lower_limit>
            <ci_upper_limit>4.30</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT ratio</param_type>
            <param_value>2.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.72</ci_lower_limit>
            <ci_upper_limit>3.80</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>6.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.09</ci_lower_limit>
            <ci_upper_limit>10.19</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.83</ci_lower_limit>
            <ci_upper_limit>4.63</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.41</ci_lower_limit>
            <ci_upper_limit>6.03</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>5.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.13</ci_lower_limit>
            <ci_upper_limit>10.82</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.30</ci_lower_limit>
            <ci_upper_limit>2.84</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>3.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.02</ci_lower_limit>
            <ci_upper_limit>4.78</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>2.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.87</ci_lower_limit>
            <ci_upper_limit>3.76</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>4.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.97</ci_lower_limit>
            <ci_upper_limit>6.58</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMT ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMT Ratio</param_type>
            <param_value>5.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.20</ci_lower_limit>
            <ci_upper_limit>9.41</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving OPA Titers With at Least Lower Limit of Quantification (LLOQ) 1 Month After Vaccination 1</title>
        <description>Percentage of participants achieving OPA GMTs with at least LLOQ for 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) determined in blood samples of all participants using mcOPA assay. Exact 2-sided CI based on observed proportion of participants. LLOQ for each serotype: 1=1:18, 3=1:12, 4=1:21, 5=1:29, 6A=1:37, 6B=1:43, 7F=1:210, 9V=1:345, 14=1:35, 18C=1:31, 19A=1:18, 19F=1:48, 23F=1:13.</description>
        <time_frame>One month after vaccination 1</time_frame>
        <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]).</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
          <group group_id="O3">
            <title>13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
          <group group_id="O4">
            <title>13vPnC, Cohort 3</title>
            <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving OPA Titers With at Least Lower Limit of Quantification (LLOQ) 1 Month After Vaccination 1</title>
          <description>Percentage of participants achieving OPA GMTs with at least LLOQ for 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) determined in blood samples of all participants using mcOPA assay. Exact 2-sided CI based on observed proportion of participants. LLOQ for each serotype: 1=1:18, 3=1:12, 4=1:21, 5=1:29, 6A=1:37, 6B=1:43, 7F=1:210, 9V=1:345, 14=1:35, 18C=1:31, 19A=1:18, 19F=1:48, 23F=1:13.</description>
          <population>Evaluable immunogenicity population:eligible participants, received vaccination to which randomized, blood drawn within required timeframes, at least 1 valid, determinate assay result for proposed analysis, received no prohibited vaccines, no major protocol violations. n= number of participants with determinate OPA antibody titer to given serotype.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="411"/>
                <count group_id="O2" value="407"/>
                <count group_id="O3" value="388"/>
                <count group_id="O4" value="874"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 (n= 404, 402, 382, 866)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.3" lower_limit="87.0" upper_limit="93.0"/>
                    <measurement group_id="O2" value="83.8" lower_limit="79.9" upper_limit="87.3"/>
                    <measurement group_id="O3" value="94.0" lower_limit="91.1" upper_limit="96.1"/>
                    <measurement group_id="O4" value="97.6" lower_limit="96.3" upper_limit="98.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 (n= 394, 401, 379, 860)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="89.0" upper_limit="94.6"/>
                    <measurement group_id="O2" value="88.3" lower_limit="84.7" upper_limit="91.3"/>
                    <measurement group_id="O3" value="92.3" lower_limit="89.2" upper_limit="94.8"/>
                    <measurement group_id="O4" value="94.8" lower_limit="93.1" upper_limit="96.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 (n= 359, 367, 350, 849)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.0" lower_limit="92.2" upper_limit="97.0"/>
                    <measurement group_id="O2" value="91.6" lower_limit="88.2" upper_limit="94.2"/>
                    <measurement group_id="O3" value="97.4" lower_limit="95.2" upper_limit="98.8"/>
                    <measurement group_id="O4" value="99.2" lower_limit="98.3" upper_limit="99.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 (n= 392, 393, 373, 836)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.0" lower_limit="83.3" upper_limit="90.2"/>
                    <measurement group_id="O2" value="84.7" lower_limit="80.8" upper_limit="88.1"/>
                    <measurement group_id="O3" value="86.1" lower_limit="82.1" upper_limit="89.4"/>
                    <measurement group_id="O4" value="92.1" lower_limit="90.1" upper_limit="93.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6A (n= 401, 392, 384, 855)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" lower_limit="93.3" upper_limit="97.5"/>
                    <measurement group_id="O2" value="69.1" lower_limit="64.3" upper_limit="73.7"/>
                    <measurement group_id="O3" value="97.9" lower_limit="95.9" upper_limit="99.1"/>
                    <measurement group_id="O4" value="99.4" lower_limit="98.6" upper_limit="99.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6B (n= 371, 371, 361, 865)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" lower_limit="90.5" upper_limit="95.8"/>
                    <measurement group_id="O2" value="86.0" lower_limit="82.0" upper_limit="89.4"/>
                    <measurement group_id="O3" value="97.5" lower_limit="95.3" upper_limit="98.9"/>
                    <measurement group_id="O4" value="99.9" lower_limit="99.4" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7F (n= 394, 396, 378, 859)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4" lower_limit="87.0" upper_limit="93.1"/>
                    <measurement group_id="O2" value="78.0" lower_limit="73.6" upper_limit="82.0"/>
                    <measurement group_id="O3" value="94.7" lower_limit="91.9" upper_limit="96.7"/>
                    <measurement group_id="O4" value="98.6" lower_limit="97.6" upper_limit="99.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9V (n= 367,368, 364, 844)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.9" lower_limit="86.4" upper_limit="92.8"/>
                    <measurement group_id="O2" value="75.8" lower_limit="71.1" upper_limit="80.1"/>
                    <measurement group_id="O3" value="93.7" lower_limit="90.7" upper_limit="96.0"/>
                    <measurement group_id="O4" value="97.7" lower_limit="96.5" upper_limit="98.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 (n= 375, 378, 373, 860)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.7" lower_limit="84.0" upper_limit="90.9"/>
                    <measurement group_id="O2" value="88.6" lower_limit="85.0" upper_limit="91.6"/>
                    <measurement group_id="O3" value="92.0" lower_limit="88.7" upper_limit="94.5"/>
                    <measurement group_id="O4" value="99.0" lower_limit="98.0" upper_limit="99.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18C (n= 379, 381, 373, 850)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.5" lower_limit="92.9" upper_limit="97.4"/>
                    <measurement group_id="O2" value="89.0" lower_limit="85.4" upper_limit="91.9"/>
                    <measurement group_id="O3" value="94.9" lower_limit="92.2" upper_limit="96.9"/>
                    <measurement group_id="O4" value="98.6" lower_limit="97.5" upper_limit="99.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19A (n= 392, 388, 377, 855)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.5" lower_limit="96.7" upper_limit="99.4"/>
                    <measurement group_id="O2" value="94.3" lower_limit="91.5" upper_limit="96.4"/>
                    <measurement group_id="O3" value="98.4" lower_limit="96.6" upper_limit="99.4"/>
                    <measurement group_id="O4" value="99.9" lower_limit="99.4" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19F (n= 377, 370, 367, 841)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7" lower_limit="86.1" upper_limit="92.5"/>
                    <measurement group_id="O2" value="90.8" lower_limit="87.4" upper_limit="93.6"/>
                    <measurement group_id="O3" value="91.6" lower_limit="88.2" upper_limit="94.2"/>
                    <measurement group_id="O4" value="98.1" lower_limit="96.9" upper_limit="98.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23F (n= 375, 375, 368, 851)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.5" lower_limit="80.5" upper_limit="88.0"/>
                    <measurement group_id="O2" value="61.3" lower_limit="56.2" upper_limit="66.3"/>
                    <measurement group_id="O3" value="85.1" lower_limit="81.0" upper_limit="88.5"/>
                    <measurement group_id="O4" value="95.1" lower_limit="93.4" upper_limit="96.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: Difference (13vPnC – 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>6.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.9</ci_lower_limit>
            <ci_upper_limit>11.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.3</ci_lower_limit>
            <ci_upper_limit>8.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.2</ci_lower_limit>
            <ci_upper_limit>7.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>2.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.6</ci_lower_limit>
            <ci_upper_limit>7.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>26.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>21.7</ci_lower_limit>
            <ci_upper_limit>31.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>7.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>3.2</ci_lower_limit>
            <ci_upper_limit>12.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>12.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>7.3</ci_lower_limit>
            <ci_upper_limit>17.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>14.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>8.7</ci_lower_limit>
            <ci_upper_limit>19.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>-0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.6</ci_lower_limit>
            <ci_upper_limit>3.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>6.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.6</ci_lower_limit>
            <ci_upper_limit>10.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>4.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.2</ci_lower_limit>
            <ci_upper_limit>7.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>-1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.5</ci_lower_limit>
            <ci_upper_limit>3.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: Difference (13vPnC - 23vPS) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>23.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>17.0</ci_lower_limit>
            <ci_upper_limit>29.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.2</ci_lower_limit>
            <ci_upper_limit>7.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>0.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.6</ci_lower_limit>
            <ci_upper_limit>4.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>2.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.4</ci_lower_limit>
            <ci_upper_limit>5.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>-0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-5.8</ci_lower_limit>
            <ci_upper_limit>3.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>2.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.4</ci_lower_limit>
            <ci_upper_limit>4.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>4.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.8</ci_lower_limit>
            <ci_upper_limit>7.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>4.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.6</ci_lower_limit>
            <ci_upper_limit>8.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.3</ci_lower_limit>
            <ci_upper_limit>7.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Perecentage</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1</ci_lower_limit>
            <ci_upper_limit>8.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>-0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.8</ci_lower_limit>
            <ci_upper_limit>2.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>-0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.1</ci_lower_limit>
            <ci_upper_limit>1.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>1.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.4</ci_lower_limit>
            <ci_upper_limit>6.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: Difference (cohort 2 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>0.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.7</ci_lower_limit>
            <ci_upper_limit>5.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>7.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.3</ci_lower_limit>
            <ci_upper_limit>10.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>2.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.3</ci_lower_limit>
            <ci_upper_limit>5.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>4.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.1</ci_lower_limit>
            <ci_upper_limit>6.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>5.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.4</ci_lower_limit>
            <ci_upper_limit>9.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 6A: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.7</ci_lower_limit>
            <ci_upper_limit>6.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>6.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.1</ci_lower_limit>
            <ci_upper_limit>9.3</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>8.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>5.4</ci_lower_limit>
            <ci_upper_limit>11.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>7.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>4.8</ci_lower_limit>
            <ci_upper_limit>11.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>11.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>8.0</ci_lower_limit>
            <ci_upper_limit>14.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>3.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.9</ci_lower_limit>
            <ci_upper_limit>5.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>1.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.3</ci_lower_limit>
            <ci_upper_limit>3.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>8.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>5.4</ci_lower_limit>
            <ci_upper_limit>12.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: Difference (cohort 3 – cohort 1) in proportions, expressed as a percentage presented along with exact 2-sided 95%CI.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than -0.10.</non_inferiority_desc>
            <param_type>Difference in Percentage</param_type>
            <param_value>10.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>6.8</ci_lower_limit>
            <ci_upper_limit>14.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) for the 13 Serotypes From Prevaccination 1 to 1 Month After Vaccination 2 in Cohort 1 and Cohort 2</title>
        <description>Geometric mean fold rises (GMFRs) for the 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) from prevaccination to 1 month postvaccination were computed using the logarithmically transformed assay results. CI for the GMFRs are back transformations of a CI based on the Student t distribution for the logarithmically transformed assay results.</description>
        <time_frame>Prevaccination 1 to 1 month after vaccination 2/Year 3 to 4</time_frame>
        <population>Evaluable immunogenicity population; n= number of participants with valid and determinate assay results for the specified serotype at both sampling times.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC/13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2 [Vax2]) at Year 3 to 4.</description>
          </group>
          <group group_id="O2">
            <title>13vPnC/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O3">
            <title>23vPS/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 23vPS at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O4">
            <title>13vPnC/13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age who received 13vPnC at vaccination 1 received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2) at Year 3 to 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Pneumococcal Opsonophagocytic Activity (OPA) Geometric Mean Fold Rises (GMFRs) for the 13 Serotypes From Prevaccination 1 to 1 Month After Vaccination 2 in Cohort 1 and Cohort 2</title>
          <description>Geometric mean fold rises (GMFRs) for the 13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) from prevaccination to 1 month postvaccination were computed using the logarithmically transformed assay results. CI for the GMFRs are back transformations of a CI based on the Student t distribution for the logarithmically transformed assay results.</description>
          <population>Evaluable immunogenicity population; n= number of participants with valid and determinate assay results for the specified serotype at both sampling times.</population>
          <units>Fold Rise</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="108"/>
                <count group_id="O3" value="189"/>
                <count group_id="O4" value="211"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 (n= 102, 103, 185, 202)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.6" lower_limit="53.90" upper_limit="97.82"/>
                    <measurement group_id="O2" value="69.7" lower_limit="51.85" upper_limit="93.79"/>
                    <measurement group_id="O3" value="15.6" lower_limit="12.38" upper_limit="19.73"/>
                    <measurement group_id="O4" value="54.0" lower_limit="43.92" upper_limit="66.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 (n= 98, 100, 176, 198)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.2" lower_limit="9.98" upper_limit="17.33"/>
                    <measurement group_id="O2" value="21.2" lower_limit="15.46" upper_limit="29.15"/>
                    <measurement group_id="O3" value="6.8" lower_limit="5.49" upper_limit="8.54"/>
                    <measurement group_id="O4" value="11.5" lower_limit="9.51" upper_limit="13.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 (n= 85, 87, 136, 165)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.0" lower_limit="40.04" upper_limit="115.58"/>
                    <measurement group_id="O2" value="110.4" lower_limit="66.47" upper_limit="183.22"/>
                    <measurement group_id="O3" value="43.8" lower_limit="27.87" upper_limit="68.74"/>
                    <measurement group_id="O4" value="104.2" lower_limit="70.96" upper_limit="152.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 (n= 101, 103, 177, 201)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.9" lower_limit="33.51" upper_limit="68.52"/>
                    <measurement group_id="O2" value="83.2" lower_limit="60.56" upper_limit="114.26"/>
                    <measurement group_id="O3" value="11.9" lower_limit="8.94" upper_limit="15.71"/>
                    <measurement group_id="O4" value="52.8" lower_limit="41.81" upper_limit="66.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6A (n= 93, 99, 166, 189)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="142.0" lower_limit="84.10" upper_limit="239.68"/>
                    <measurement group_id="O2" value="116.2" lower_limit="71.19" upper_limit="189.69"/>
                    <measurement group_id="O3" value="6.4" lower_limit="4.25" upper_limit="9.53"/>
                    <measurement group_id="O4" value="139.7" lower_limit="93.99" upper_limit="207.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6B (n= 89, 89, 157, 181)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.3" lower_limit="57.72" upper_limit="184.69"/>
                    <measurement group_id="O2" value="63.6" lower_limit="34.73" upper_limit="116.29"/>
                    <measurement group_id="O3" value="24.9" lower_limit="15.98" upper_limit="38.77"/>
                    <measurement group_id="O4" value="132.7" lower_limit="84.86" upper_limit="207.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7F (n= 97, 100, 173, 193)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="140.8" lower_limit="91.49" upper_limit="216.59"/>
                    <measurement group_id="O2" value="293.9" lower_limit="203.35" upper_limit="424.67"/>
                    <measurement group_id="O3" value="72.1" lower_limit="50.27" upper_limit="103.53"/>
                    <measurement group_id="O4" value="218.0" lower_limit="169.33" upper_limit="280.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9V (n= 85, 93, 147, 172)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.7" lower_limit="12.86" upper_limit="47.32"/>
                    <measurement group_id="O2" value="40.1" lower_limit="21.13" upper_limit="76.11"/>
                    <measurement group_id="O3" value="10.6" lower_limit="6.52" upper_limit="17.13"/>
                    <measurement group_id="O4" value="49.9" lower_limit="32.88" upper_limit="75.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 (n= 95, 97, 165, 189)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.6" lower_limit="12.31" upper_limit="34.57"/>
                    <measurement group_id="O2" value="36.6" lower_limit="22.02" upper_limit="60.97"/>
                    <measurement group_id="O3" value="19.9" lower_limit="13.85" upper_limit="28.67"/>
                    <measurement group_id="O4" value="26.6" lower_limit="18.43" upper_limit="38.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18C (n= 95, 97, 170, 191)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.9" lower_limit="41.02" upper_limit="112.48"/>
                    <measurement group_id="O2" value="80.9" lower_limit="48.89" upper_limit="133.79"/>
                    <measurement group_id="O3" value="27.5" lower_limit="19.10" upper_limit="39.69"/>
                    <measurement group_id="O4" value="94.9" lower_limit="67.89" upper_limit="132.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19A (n= 96, 93, 168, 196)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.6" lower_limit="25.57" upper_limit="55.37"/>
                    <measurement group_id="O2" value="43.1" lower_limit="29.21" upper_limit="63.51"/>
                    <measurement group_id="O3" value="15.4" lower_limit="11.79" upper_limit="20.25"/>
                    <measurement group_id="O4" value="30.9" lower_limit="23.56" upper_limit="40.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19F (n= 93, 93, 160, 186)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.1" lower_limit="34.08" upper_limit="86.01"/>
                    <measurement group_id="O2" value="110.3" lower_limit="71.30" upper_limit="170.65"/>
                    <measurement group_id="O3" value="25.1" lower_limit="18.04" upper_limit="34.84"/>
                    <measurement group_id="O4" value="60.4" lower_limit="43.40" upper_limit="84.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23F (n= 95, 97, 169, 188)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="115.7" lower_limit="77.40" upper_limit="172.81"/>
                    <measurement group_id="O2" value="32.5" lower_limit="21.38" upper_limit="49.40"/>
                    <measurement group_id="O3" value="6.4" lower_limit="4.57" upper_limit="8.85"/>
                    <measurement group_id="O4" value="130.0" lower_limit="94.64" upper_limit="178.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMC) for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS and 23vPS/23vPS Groups in Cohort 1; and in 13vPnC/13vPnC Group in Cohort 2, 1 Month After Vaccination</title>
        <description>Antibody geometric mean concentration (GMC) as measured by microgram/milliliter (mcg/mL) for 12 common pneumococcal serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) are presented. GMC and corresponding 2-sided 95% confidence intervals (CI) were evaluated. Geometric means (GMs) were calculated using all participants with available data for the specified blood draw.</description>
        <time_frame>One month after vaccination 1 and One month after vaccination 2/Year 3 to 4</time_frame>
        <population>Evaluable immunogenicity population; n= number of participants with a determinate IgG concentration to the given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
          <group group_id="O3">
            <title>23vPs/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 23vPS at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O4">
            <title>13vPnC/13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2) at Year 3 to 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Serotype-specific Pneumococcal Immunoglobulin G (IgG) Geometric Mean Concentration (GMC) for 12 Common Serotypes in 13vPnC/23vPS Group Relative to 23vPS and 23vPS/23vPS Groups in Cohort 1; and in 13vPnC/13vPnC Group in Cohort 2, 1 Month After Vaccination</title>
          <description>Antibody geometric mean concentration (GMC) as measured by microgram/milliliter (mcg/mL) for 12 common pneumococcal serotypes (1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F) are presented. GMC and corresponding 2-sided 95% confidence intervals (CI) were evaluated. Geometric means (GMs) were calculated using all participants with available data for the specified blood draw.</description>
          <population>Evaluable immunogenicity population; n= number of participants with a determinate IgG concentration to the given serotype.</population>
          <units>mcg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="108"/>
                <count group_id="O2" value="407"/>
                <count group_id="O3" value="189"/>
                <count group_id="O4" value="211"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>1 (n= 99, 48, 98, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.53" lower_limit="7.53" upper_limit="12.07"/>
                    <measurement group_id="O2" value="4.13" lower_limit="2.86" upper_limit="5.96"/>
                    <measurement group_id="O3" value="4.36" lower_limit="3.33" upper_limit="5.72"/>
                    <measurement group_id="O4" value="6.92" lower_limit="5.31" upper_limit="9.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 (n= 99, 46, 98, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" lower_limit="2.14" upper_limit="3.11"/>
                    <measurement group_id="O2" value="1.88" lower_limit="1.29" upper_limit="2.74"/>
                    <measurement group_id="O3" value="1.81" lower_limit="1.44" upper_limit="2.29"/>
                    <measurement group_id="O4" value="1.33" lower_limit="1.07" upper_limit="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 (n= 99, 48, 98, 93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.68" lower_limit="2.86" upper_limit="4.74"/>
                    <measurement group_id="O2" value="1.59" lower_limit="1.06" upper_limit="2.37"/>
                    <measurement group_id="O3" value="1.49" lower_limit="1.14" upper_limit="1.95"/>
                    <measurement group_id="O4" value="4.89" lower_limit="3.83" upper_limit="6.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5 (n= 99, 47, 98, 97)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.52" lower_limit="9.09" upper_limit="14.61"/>
                    <measurement group_id="O2" value="8.23" lower_limit="5.81" upper_limit="11.67"/>
                    <measurement group_id="O3" value="5.78" lower_limit="4.66" upper_limit="7.16"/>
                    <measurement group_id="O4" value="7.23" lower_limit="5.67" upper_limit="9.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6B (n= 98, 47, 98, 97)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.50" lower_limit="9.21" upper_limit="14.37"/>
                    <measurement group_id="O2" value="7.81" lower_limit="5.74" upper_limit="10.61"/>
                    <measurement group_id="O3" value="5.65" lower_limit="4.58" upper_limit="6.97"/>
                    <measurement group_id="O4" value="19.07" lower_limit="14.59" upper_limit="24.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7F (n= 98, 47, 97, 95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.52" lower_limit="6.83" upper_limit="10.62"/>
                    <measurement group_id="O2" value="8.24" lower_limit="5.38" upper_limit="12.60"/>
                    <measurement group_id="O3" value="4.61" lower_limit="3.57" upper_limit="5.95"/>
                    <measurement group_id="O4" value="6.26" lower_limit="5.19" upper_limit="7.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9V (n= 99, 47, 97, 97)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.39" lower_limit="5.99" upper_limit="9.10"/>
                    <measurement group_id="O2" value="5.50" lower_limit="4.15" upper_limit="7.30"/>
                    <measurement group_id="O3" value="3.78" lower_limit="3.07" upper_limit="4.65"/>
                    <measurement group_id="O4" value="4.97" lower_limit="4.08" upper_limit="6.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 (n= 97, 47, 98, 97)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.07" lower_limit="12.31" upper_limit="20.98"/>
                    <measurement group_id="O2" value="12.05" lower_limit="7.26" upper_limit="19.99"/>
                    <measurement group_id="O3" value="8.22" lower_limit="6.11" upper_limit="11.05"/>
                    <measurement group_id="O4" value="14.66" lower_limit="11.97" upper_limit="17.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18C (n= 98, 48, 98, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.56" lower_limit="6.77" upper_limit="10.84"/>
                    <measurement group_id="O2" value="8.21" lower_limit="5.64" upper_limit="11.96"/>
                    <measurement group_id="O3" value="6.30" lower_limit="4.70" upper_limit="8.45"/>
                    <measurement group_id="O4" value="7.17" lower_limit="5.68" upper_limit="9.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19A (n= 98, 48, 98, 98)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.63" lower_limit="11.87" upper_limit="18.04"/>
                    <measurement group_id="O2" value="12.70" lower_limit="9.29" upper_limit="17.37"/>
                    <measurement group_id="O3" value="9.88" lower_limit="7.80" upper_limit="12.52"/>
                    <measurement group_id="O4" value="16.33" lower_limit="13.31" upper_limit="20.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>19F (n= 98, 46, 97, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.51" lower_limit="8.64" upper_limit="15.34"/>
                    <measurement group_id="O2" value="6.42" lower_limit="4.11" upper_limit="10.01"/>
                    <measurement group_id="O3" value="3.44" lower_limit="2.50" upper_limit="4.73"/>
                    <measurement group_id="O4" value="12.89" lower_limit="9.75" upper_limit="17.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23F (n= 98, 48, 97, 96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.11" lower_limit="5.50" upper_limit="9.19"/>
                    <measurement group_id="O2" value="4.89" lower_limit="3.52" upper_limit="6.81"/>
                    <measurement group_id="O3" value="3.56" lower_limit="2.81" upper_limit="4.52"/>
                    <measurement group_id="O4" value="17.20" lower_limit="13.28" upper_limit="22.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.31</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.52</ci_lower_limit>
            <ci_upper_limit>3.51</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>1.99</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.32</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.47</ci_lower_limit>
            <ci_upper_limit>3.64</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.40</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>2.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.47</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.01</ci_lower_limit>
            <ci_upper_limit>2.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.03</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.67</ci_lower_limit>
            <ci_upper_limit>1.59</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.92</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>2.23</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.68</ci_lower_limit>
            <ci_upper_limit>1.59</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.80</ci_lower_limit>
            <ci_upper_limit>1.66</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>1.07</ci_lower_limit>
            <ci_upper_limit>3.00</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.45</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.95</ci_lower_limit>
            <ci_upper_limit>2.24</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 1: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.53</ci_lower_limit>
            <ci_upper_limit>3.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 3: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.42</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.06</ci_lower_limit>
            <ci_upper_limit>1.91</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 4: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.47</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.71</ci_lower_limit>
            <ci_upper_limit>3.55</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 5: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.99</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.45</ci_lower_limit>
            <ci_upper_limit>2.74</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 6B: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.04</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.50</ci_lower_limit>
            <ci_upper_limit>2.76</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 7F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.85</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.32</ci_lower_limit>
            <ci_upper_limit>2.58</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 9V: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.46</ci_lower_limit>
            <ci_upper_limit>2.62</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 14: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.32</ci_lower_limit>
            <ci_upper_limit>2.91</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 18C: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.36</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.94</ci_lower_limit>
            <ci_upper_limit>1.97</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19A: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>1.48</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.08</ci_lower_limit>
            <ci_upper_limit>2.03</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 19F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>3.35</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>2.19</ci_lower_limit>
            <ci_upper_limit>5.12</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Serotype 23F: CI for the GMC ratio was calculated by the back transformations of CI based on the Student t distribution for the mean difference of the logarithms of the measures (13vPnC/23vPS - 23vPS/23vPS).</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority was to be concluded if the lower bound of the 2-sided 95% CI was greater than 0.5.</non_inferiority_desc>
            <param_type>GMC Ratio</param_type>
            <param_value>2.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.41</ci_lower_limit>
            <ci_upper_limit>2.83</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 1</title>
        <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 centimeters [cm]; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation [lim] present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
        <time_frame>Within 14 days after vaccination 1</time_frame>
        <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed )=participants with known values for any local reaction. 'n'=number of participants with known values for specified local reaction for each group respectively. Participants may be represented in more than 1 category.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]).</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose (Vaccination 1).</description>
          </group>
          <group group_id="O3">
            <title>13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose at (Vaccination 1).</description>
          </group>
          <group group_id="O4">
            <title>13vPnC, Cohort 3</title>
            <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 1</title>
          <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 centimeters [cm]; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation [lim] present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
          <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed )=participants with known values for any local reaction. 'n'=number of participants with known values for specified local reaction for each group respectively. Participants may be represented in more than 1 category.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="337"/>
                <count group_id="O2" value="307"/>
                <count group_id="O3" value="327"/>
                <count group_id="O4" value="801"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Redness: Any (n= 193, 190, 152, 266)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.2" lower_limit="14.8" upper_limit="26.6"/>
                    <measurement group_id="O2" value="14.2" lower_limit="9.6" upper_limit="20.0"/>
                    <measurement group_id="O3" value="15.8" lower_limit="10.4" upper_limit="22.6"/>
                    <measurement group_id="O4" value="30.5" lower_limit="25.0" upper_limit="36.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Mild (n= 189, 187, 151, 258)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.9" lower_limit="11.0" upper_limit="21.9"/>
                    <measurement group_id="O2" value="11.2" lower_limit="7.1" upper_limit="16.7"/>
                    <measurement group_id="O3" value="15.2" lower_limit="9.9" upper_limit="22.0"/>
                    <measurement group_id="O4" value="26.4" lower_limit="21.1" upper_limit="32.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Moderate (n= 185, 182, 140, 227)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.6" lower_limit="5.0" upper_limit="13.7"/>
                    <measurement group_id="O2" value="4.9" lower_limit="2.3" upper_limit="9.2"/>
                    <measurement group_id="O3" value="5.0" lower_limit="2.0" upper_limit="10.0"/>
                    <measurement group_id="O4" value="11.9" lower_limit="8.0" upper_limit="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Severe (n= 178, 179, 137, 211)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="0.3" upper_limit="4.8"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="0.2"/>
                    <measurement group_id="O3" value="0.7" lower_limit="0.0" upper_limit="4.0"/>
                    <measurement group_id="O4" value="2.8" lower_limit="1.1" upper_limit="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Any (n= 197, 191, 161, 302)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.3" lower_limit="14.0" upper_limit="25.5"/>
                    <measurement group_id="O2" value="13.1" lower_limit="8.7" upper_limit="18.7"/>
                    <measurement group_id="O3" value="21.7" lower_limit="15.6" upper_limit="28.9"/>
                    <measurement group_id="O4" value="39.4" lower_limit="33.9" upper_limit="45.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Mild (n= 192, 189, 160, 293)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" lower_limit="10.8" upper_limit="21.5"/>
                    <measurement group_id="O2" value="10.1" lower_limit="6.2" upper_limit="15.3"/>
                    <measurement group_id="O3" value="20.6" lower_limit="14.6" upper_limit="27.7"/>
                    <measurement group_id="O4" value="37.2" lower_limit="31.7" upper_limit="43.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Moderate (n= 184, 181, 138, 238)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.2" lower_limit="4.6" upper_limit="13.1"/>
                    <measurement group_id="O2" value="4.4" lower_limit="1.9" upper_limit="8.5"/>
                    <measurement group_id="O3" value="4.3" lower_limit="1.6" upper_limit="9.2"/>
                    <measurement group_id="O4" value="15.1" lower_limit="10.8" upper_limit="20.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Severe (n= 178, 180, 136, 209)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" lower_limit="0.0" upper_limit="3.1"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0.1" upper_limit="4.0"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="2.7"/>
                    <measurement group_id="O4" value="1.4" lower_limit="0.3" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Any (n= 331, 301, 322, 787)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.1" lower_limit="75.3" upper_limit="84.2"/>
                    <measurement group_id="O2" value="73.4" lower_limit="68.1" upper_limit="78.3"/>
                    <measurement group_id="O3" value="88.8" lower_limit="84.9" upper_limit="92.0"/>
                    <measurement group_id="O4" value="96.7" lower_limit="95.2" upper_limit="97.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Mild (n= 323, 290, 306, 721)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.6" lower_limit="73.8" upper_limit="83.0"/>
                    <measurement group_id="O2" value="68.6" lower_limit="62.9" upper_limit="73.9"/>
                    <measurement group_id="O3" value="85.9" lower_limit="81.5" upper_limit="89.6"/>
                    <measurement group_id="O4" value="93.2" lower_limit="91.1" upper_limit="94.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Moderate (n= 206, 210, 190, 467)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.3" lower_limit="17.7" upper_limit="29.7"/>
                    <measurement group_id="O2" value="30.0" lower_limit="23.9" upper_limit="36.7"/>
                    <measurement group_id="O3" value="39.5" lower_limit="32.5" upper_limit="46.8"/>
                    <measurement group_id="O4" value="77.1" lower_limit="73.0" upper_limit="80.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Severe (n= 178, 187, 139, 238)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="0.3" upper_limit="4.8"/>
                    <measurement group_id="O2" value="8.6" lower_limit="5.0" upper_limit="13.5"/>
                    <measurement group_id="O3" value="3.6" lower_limit="1.2" upper_limit="8.2"/>
                    <measurement group_id="O4" value="16.0" lower_limit="11.6" upper_limit="21.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lim of arm movement:Any (n= 214, 211, 194, 499)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.5" lower_limit="22.6" upper_limit="35.1"/>
                    <measurement group_id="O2" value="30.8" lower_limit="24.6" upper_limit="37.5"/>
                    <measurement group_id="O3" value="40.7" lower_limit="33.7" upper_limit="48.0"/>
                    <measurement group_id="O4" value="75.2" lower_limit="71.1" upper_limit="78.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lim of arm movement:Mild (n= 212, 208, 189, 466)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.9" lower_limit="21.0" upper_limit="33.4"/>
                    <measurement group_id="O2" value="29.3" lower_limit="23.2" upper_limit="36.0"/>
                    <measurement group_id="O3" value="38.6" lower_limit="31.6" upper_limit="46.0"/>
                    <measurement group_id="O4" value="71.5" lower_limit="67.1" upper_limit="75.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lim of arm movement:Moderate(n= 179, 182,140, 238)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" lower_limit="0.6" upper_limit="5.6"/>
                    <measurement group_id="O2" value="3.8" lower_limit="1.6" upper_limit="7.8"/>
                    <measurement group_id="O3" value="2.9" lower_limit="0.8" upper_limit="7.2"/>
                    <measurement group_id="O4" value="18.5" lower_limit="13.8" upper_limit="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lim of arm movement:Severe (n= 180, 185, 139, 237)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" lower_limit="0.3" upper_limit="4.8"/>
                    <measurement group_id="O2" value="4.3" lower_limit="1.9" upper_limit="8.3"/>
                    <measurement group_id="O3" value="2.9" lower_limit="0.8" upper_limit="7.2"/>
                    <measurement group_id="O4" value="15.6" lower_limit="11.2" upper_limit="20.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</title>
        <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 cm; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
        <time_frame>Within 14 days after vaccination 2</time_frame>
        <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed)=participants with known values for any local reaction. 'n'=number of participants with known values for specified local reaction for each group respectively. Participants may be represented in more than 1 category.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC/13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2 [Vax2]) at Year 3 to 4.</description>
          </group>
          <group group_id="O2">
            <title>23vPS/23vPS, Cohort 1</title>
            <description>Participants aged 60-64 years of age who received 23vPS at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O3">
            <title>13vPnC/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O4">
            <title>13vPnC/13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age who received 13vPnC at vaccination 1 received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2) at Year 3 to 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Local Reactions Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</title>
          <description>Local reactions reported using an electronic diary. Redness and Swelling scaled as Any (redness present or swelling present); Mild (2.5 to 5.0 cm; Moderate (5.1 to 10.0 cm); Severe (&gt;10 cm). Pain scaled as Any (pain present); Mild (awareness of pain; easily tolerated); Moderate (discomfort enough to cause interference with usual activity); Severe (incapacitating); Limitation of arm movement scaled as Any (limitation present); Mild (some limitation); Moderate (unable to move arm above head; able to move arm above shoulder); Severe (unable to move arm above shoulder).</description>
          <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed)=participants with known values for any local reaction. 'n'=number of participants with known values for specified local reaction for each group respectively. Participants may be represented in more than 1 category.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="167"/>
                <count group_id="O3" value="89"/>
                <count group_id="O4" value="174"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Redness: Any (n=50,109,51,84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="10.0" upper_limit="33.7"/>
                    <measurement group_id="O2" value="35.8" lower_limit="26.8" upper_limit="45.5"/>
                    <measurement group_id="O3" value="27.5" lower_limit="15.9" upper_limit="41.7"/>
                    <measurement group_id="O4" value="21.4" lower_limit="13.2" upper_limit="31.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Mild (n=50,101,49,83)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="10.0" upper_limit="33.7"/>
                    <measurement group_id="O2" value="27.7" lower_limit="19.3" upper_limit="37.5"/>
                    <measurement group_id="O3" value="22.4" lower_limit="11.8" upper_limit="36.6"/>
                    <measurement group_id="O4" value="18.1" lower_limit="10.5" upper_limit="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Moderate (n=48,91,44,75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" lower_limit="1.3" upper_limit="17.2"/>
                    <measurement group_id="O2" value="18.7" lower_limit="11.3" upper_limit="28.2"/>
                    <measurement group_id="O3" value="11.4" lower_limit="3.8" upper_limit="24.6"/>
                    <measurement group_id="O4" value="5.3" lower_limit="1.5" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness: Severe (n=47,85,42,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="10.6" lower_limit="5.0" upper_limit="19.2"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O4" value="1.4" lower_limit="0.0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Any (n=53,104,49,84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5" lower_limit="13.8" upper_limit="38.3"/>
                    <measurement group_id="O2" value="35.6" lower_limit="26.4" upper_limit="45.6"/>
                    <measurement group_id="O3" value="20.4" lower_limit="10.2" upper_limit="34.3"/>
                    <measurement group_id="O4" value="22.6" lower_limit="14.2" upper_limit="33.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Mild (n=52,91,48,84)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.2" lower_limit="11.1" upper_limit="34.7"/>
                    <measurement group_id="O2" value="20.9" lower_limit="13.1" upper_limit="30.7"/>
                    <measurement group_id="O3" value="18.8" lower_limit="8.9" upper_limit="32.6"/>
                    <measurement group_id="O4" value="21.4" lower_limit="13.2" upper_limit="31.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Moderate (n=49,95,43,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.2" lower_limit="3.4" upper_limit="22.2"/>
                    <measurement group_id="O2" value="24.2" lower_limit="16.0" upper_limit="34.1"/>
                    <measurement group_id="O3" value="7.0" lower_limit="1.5" upper_limit="19.1"/>
                    <measurement group_id="O4" value="4.1" lower_limit="0.9" upper_limit="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling: Severe (n=47,82,42,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="7.3" lower_limit="2.7" upper_limit="15.2"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O4" value="1.4" lower_limit="0.0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Any (n=79,164,87,173)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.5" lower_limit="67.8" upper_limit="86.9"/>
                    <measurement group_id="O2" value="84.8" lower_limit="78.3" upper_limit="89.9"/>
                    <measurement group_id="O3" value="83.9" lower_limit="74.5" upper_limit="90.9"/>
                    <measurement group_id="O4" value="93.1" lower_limit="88.2" upper_limit="96.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Mild (n=76,156,83,165)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.3" lower_limit="65.2" upper_limit="85.3"/>
                    <measurement group_id="O2" value="80.1" lower_limit="73.0" upper_limit="86.1"/>
                    <measurement group_id="O3" value="81.9" lower_limit="72.0" upper_limit="89.5"/>
                    <measurement group_id="O4" value="90.9" lower_limit="85.4" upper_limit="94.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Moderate (n=53,111,59,112)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5" lower_limit="13.8" upper_limit="38.3"/>
                    <measurement group_id="O2" value="51.4" lower_limit="41.7" upper_limit="61.0"/>
                    <measurement group_id="O3" value="44.1" lower_limit="31.2" upper_limit="57.6"/>
                    <measurement group_id="O4" value="53.6" lower_limit="43.9" upper_limit="63.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain: Severe (n=48,86,44,75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.1" upper_limit="11.1"/>
                    <measurement group_id="O2" value="11.6" lower_limit="5.7" upper_limit="20.3"/>
                    <measurement group_id="O3" value="9.1" lower_limit="2.5" upper_limit="21.7"/>
                    <measurement group_id="O4" value="5.3" lower_limit="1.5" upper_limit="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limitation of arm movement: Any (n=54,112,57,109)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.8" lower_limit="16.5" upper_limit="41.6"/>
                    <measurement group_id="O2" value="48.2" lower_limit="38.7" upper_limit="57.9"/>
                    <measurement group_id="O3" value="42.1" lower_limit="29.1" upper_limit="55.9"/>
                    <measurement group_id="O4" value="51.4" lower_limit="41.6" upper_limit="61.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limitation of arm movement: Mild (n=54,110,57,106)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.1" lower_limit="13.5" upper_limit="37.6"/>
                    <measurement group_id="O2" value="46.4" lower_limit="36.8" upper_limit="56.1"/>
                    <measurement group_id="O3" value="40.4" lower_limit="27.6" upper_limit="54.2"/>
                    <measurement group_id="O4" value="48.1" lower_limit="38.3" upper_limit="58.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limitation of arm movement:Moderate(n=47,81,43,77)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" lower_limit="0.5" upper_limit="14.5"/>
                    <measurement group_id="O2" value="3.7" lower_limit="0.8" upper_limit="10.4"/>
                    <measurement group_id="O3" value="7.0" lower_limit="1.5" upper_limit="19.1"/>
                    <measurement group_id="O4" value="9.1" lower_limit="3.7" upper_limit="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limitation of arm movement: Severe (n=47,84,41,77)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.1" upper_limit="11.3"/>
                    <measurement group_id="O2" value="9.5" lower_limit="4.2" upper_limit="17.9"/>
                    <measurement group_id="O3" value="4.9" lower_limit="0.6" upper_limit="16.5"/>
                    <measurement group_id="O4" value="5.2" lower_limit="1.4" upper_limit="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 1</title>
        <description>Systemic events reported using an electronic diary. Systemic events are any fever greater than or equal to (&gt;=) 38 degrees Celsius [C], fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized (gen) muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain. All reports of fever &gt;40 degrees C in 13vPnC and 23vPS for Cohort 1 were confirmed as data entry errors.</description>
        <time_frame>Within 14 days after vaccination 1</time_frame>
        <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed )=participants with known values for any systemic events. 'n'=number of participants with known values for specified systemic events for each group respectively. Participants may be represented in more than 1 category.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age received 13-valent pneumococcal conjugate vaccine (13vPnC) administered as a 0.5 milliliter (mL) single dose intramuscularly (Vaccination 1 [Vax1]) at Year 0.</description>
          </group>
          <group group_id="O2">
            <title>23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a 0.5 mL single dose (Vaccination 1) at Year 0.</description>
          </group>
          <group group_id="O3">
            <title>13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age received 13vPnC administered as a 0.5 mL single dose at (Vaccination 1) Year 0.</description>
          </group>
          <group group_id="O4">
            <title>13vPnC, Cohort 3</title>
            <description>Participants 18-49 years of age received 13vPnC administered as a 0.5 mL single dose intramuscularly (Vaccination 1).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 1</title>
          <description>Systemic events reported using an electronic diary. Systemic events are any fever greater than or equal to (&gt;=) 38 degrees Celsius [C], fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized (gen) muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain. All reports of fever &gt;40 degrees C in 13vPnC and 23vPS for Cohort 1 were confirmed as data entry errors.</description>
          <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed )=participants with known values for any systemic events. 'n'=number of participants with known values for specified systemic events for each group respectively. Participants may be represented in more than 1 category.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="327"/>
                <count group_id="O2" value="330"/>
                <count group_id="O3" value="314"/>
                <count group_id="O4" value="752"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever &gt;=38 degrees C (n= 181, 185, 137, 221)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" lower_limit="4.3" upper_limit="12.6"/>
                    <measurement group_id="O2" value="5.9" lower_limit="3.0" upper_limit="10.4"/>
                    <measurement group_id="O3" value="1.5" lower_limit="0.2" upper_limit="5.2"/>
                    <measurement group_id="O4" value="7.2" lower_limit="4.2" upper_limit="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;=38 to &lt;38.5 degrees C(n=179,180,137,214)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="1.6" upper_limit="7.9"/>
                    <measurement group_id="O2" value="1.1" lower_limit="0.1" upper_limit="4.0"/>
                    <measurement group_id="O3" value="1.5" lower_limit="0.2" upper_limit="5.2"/>
                    <measurement group_id="O4" value="4.2" lower_limit="1.9" upper_limit="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;=38.5 to &lt;39 degrees C (n=178,179,136,211)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" lower_limit="0.0" upper_limit="3.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="2.0"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="2.7"/>
                    <measurement group_id="O4" value="1.9" lower_limit="0.5" upper_limit="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;=39 to =&lt;40 degrees C (n=177,179,136,210)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="2.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="2.0"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="2.7"/>
                    <measurement group_id="O4" value="1.4" lower_limit="0.3" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;40 degrees C (n= 180, 184, 136, 208)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" lower_limit="1.9" upper_limit="8.6"/>
                    <measurement group_id="O2" value="4.9" lower_limit="2.3" upper_limit="9.1"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="2.7"/>
                    <measurement group_id="O4" value="0.5" lower_limit="0.0" upper_limit="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue (n= 277, 273, 248, 554)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.2" lower_limit="57.2" upper_limit="68.9"/>
                    <measurement group_id="O2" value="61.5" lower_limit="55.5" upper_limit="67.3"/>
                    <measurement group_id="O3" value="63.3" lower_limit="57.0" upper_limit="69.3"/>
                    <measurement group_id="O4" value="80.5" lower_limit="77.0" upper_limit="83.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache (n= 252, 259, 246, 527)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.0" lower_limit="47.6" upper_limit="60.2"/>
                    <measurement group_id="O2" value="54.4" lower_limit="48.2" upper_limit="60.6"/>
                    <measurement group_id="O3" value="65.9" lower_limit="59.6" upper_limit="71.8"/>
                    <measurement group_id="O4" value="81.4" lower_limit="77.8" upper_limit="84.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills (n= 204, 199, 158, 286)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" lower_limit="17.9" upper_limit="30.0"/>
                    <measurement group_id="O2" value="24.1" lower_limit="18.4" upper_limit="30.7"/>
                    <measurement group_id="O3" value="19.6" lower_limit="13.7" upper_limit="26.7"/>
                    <measurement group_id="O4" value="38.1" lower_limit="32.5" upper_limit="44.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rash (n= 194, 192, 148, 249)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" lower_limit="11.6" upper_limit="22.5"/>
                    <measurement group_id="O2" value="13.0" lower_limit="8.6" upper_limit="18.6"/>
                    <measurement group_id="O3" value="14.2" lower_limit="9.0" upper_limit="20.9"/>
                    <measurement group_id="O4" value="21.3" lower_limit="16.4" upper_limit="26.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting (n= 180, 186, 144, 240)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="1.6" upper_limit="7.8"/>
                    <measurement group_id="O2" value="5.4" lower_limit="2.6" upper_limit="9.7"/>
                    <measurement group_id="O3" value="6.9" lower_limit="3.4" upper_limit="12.4"/>
                    <measurement group_id="O4" value="15.0" lower_limit="10.7" upper_limit="20.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased appetite (n= 202, 207, 166, 363)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.3" lower_limit="15.9" upper_limit="27.6"/>
                    <measurement group_id="O2" value="21.7" lower_limit="16.3" upper_limit="28.0"/>
                    <measurement group_id="O3" value="25.3" lower_limit="18.9" upper_limit="32.6"/>
                    <measurement group_id="O4" value="55.6" lower_limit="50.4" upper_limit="60.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New gen muscle pain (n= 249, 268, 238, 561)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.2" lower_limit="49.8" upper_limit="62.5"/>
                    <measurement group_id="O2" value="57.8" lower_limit="51.7" upper_limit="63.8"/>
                    <measurement group_id="O3" value="61.8" lower_limit="55.3" upper_limit="68.0"/>
                    <measurement group_id="O4" value="82.0" lower_limit="78.6" upper_limit="85.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aggravated gen muscle pain (n= 215, 225, 188, 370)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.6" lower_limit="26.3" upper_limit="39.3"/>
                    <measurement group_id="O2" value="37.3" lower_limit="31.0" upper_limit="44.0"/>
                    <measurement group_id="O3" value="39.9" lower_limit="32.8" upper_limit="47.3"/>
                    <measurement group_id="O4" value="55.9" lower_limit="50.7" upper_limit="61.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New gen joint pain (n= 197, 216, 165, 307)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.4" lower_limit="18.5" upper_limit="31.0"/>
                    <measurement group_id="O2" value="30.1" lower_limit="24.1" upper_limit="36.7"/>
                    <measurement group_id="O3" value="31.5" lower_limit="24.5" upper_limit="39.2"/>
                    <measurement group_id="O4" value="41.7" lower_limit="36.1" upper_limit="47.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aggravated gen joint pain (n= 205, 206, 168, 269)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.9" lower_limit="19.1" upper_limit="31.4"/>
                    <measurement group_id="O2" value="21.4" lower_limit="16.0" upper_limit="27.6"/>
                    <measurement group_id="O3" value="25.6" lower_limit="19.2" upper_limit="32.9"/>
                    <measurement group_id="O4" value="28.6" lower_limit="23.3" upper_limit="34.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</title>
        <description>Systemic events reported using an electronic diary. Systemic events are any fever &gt;=38 degrees C, fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain.</description>
        <time_frame>Within 14 days after vaccination 2</time_frame>
        <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed)=participants with known values for any systemic events. 'n'=number of participants with known values for specified systemic events for each group respectively. Participants may be represented in more than 1 category.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC/13vPnC, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2 [Vax2]) at Year 3 to 4.</description>
          </group>
          <group group_id="O2">
            <title>23vPS/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 23vPS at vaccination 1, received a 0.5 mL single dose intramuscularly of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O3">
            <title>13vPnC/23vPS, Cohort 1</title>
            <description>Participants 60-64 years of age who received 13vPnC at vaccination 1, received a 0.5 mL single dose of open-label 23vPS (Vaccination 2) at Year 3 to 4.</description>
          </group>
          <group group_id="O4">
            <title>13vPnC/13vPnC, Cohort 2</title>
            <description>Participants 50-59 years of age who received 13vPnC at vaccination 1 received a 0.5 mL single dose intramuscularly of open-label 13vPnC (Vaccination 2) at Year 3 to 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Systemic Events Within 14 Days After Vaccination 2 (Year 3 to 4) in Cohort 1 and Cohort 2</title>
          <description>Systemic events reported using an electronic diary. Systemic events are any fever &gt;=38 degrees C, fatigue, headache, chills, rash, vomiting, decreased appetite, new generalized muscle pain, aggravated generalized muscle pain , new generalized joint pain), and aggravated generalized joint pain.</description>
          <population>Safety population included all participants who received at least 1 dose of study vaccine. 'N' (number of participants analyzed)=participants with known values for any systemic events. 'n'=number of participants with known values for specified systemic events for each group respectively. Participants may be represented in more than 1 category.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
                <count group_id="O2" value="162"/>
                <count group_id="O3" value="83"/>
                <count group_id="O4" value="167"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fever &gt;=38 degrees C, (n= 48,79,43,75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.1" upper_limit="11.1"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.3" upper_limit="8.8"/>
                    <measurement group_id="O3" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O4" value="2.7" lower_limit="0.3" upper_limit="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;= 38 to &lt;38.5 degrees C (n= 47,79,42,75)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.3" upper_limit="8.8"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O4" value="2.7" lower_limit="0.3" upper_limit="9.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;=38.5 to &lt;39 degrees C (n= 48,78,42,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.1" upper_limit="11.1"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="4.6"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.1" upper_limit="12.6"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;=39 to =&lt;40 degrees C (n= 47,78,41,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="4.6"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever &gt;40 degrees C (n= 47,78,41,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0" lower_limit="0.0" upper_limit="7.5"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="4.6"/>
                    <measurement group_id="O3" value="0.0" lower_limit="0.0" upper_limit="8.6"/>
                    <measurement group_id="O4" value="0.0" lower_limit="0.0" upper_limit="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fatigue (n= 69,125,68,125)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.7" lower_limit="38.4" upper_limit="63.03"/>
                    <measurement group_id="O2" value="57.6" lower_limit="48.4" upper_limit="66.4"/>
                    <measurement group_id="O3" value="63.2" lower_limit="50.7" upper_limit="74.6"/>
                    <measurement group_id="O4" value="60.8" lower_limit="51.7" upper_limit="69.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache (n= 60,118,64,123)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.3" lower_limit="26.1" upper_limit="51.8"/>
                    <measurement group_id="O2" value="54.2" lower_limit="44.8" upper_limit="63.4"/>
                    <measurement group_id="O3" value="50.0" lower_limit="37.2" upper_limit="62.8"/>
                    <measurement group_id="O4" value="61.8" lower_limit="52.6" upper_limit="70.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chills (n= 52,99,56,93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1" lower_limit="12.5" upper_limit="36.8"/>
                    <measurement group_id="O2" value="34.3" lower_limit="25.1" upper_limit="44.6"/>
                    <measurement group_id="O3" value="33.9" lower_limit="21.8" upper_limit="47.8"/>
                    <measurement group_id="O4" value="25.8" lower_limit="17.3" upper_limit="35.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rash (n= 51,95,49,81)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.5" lower_limit="12.8" upper_limit="37.5"/>
                    <measurement group_id="O2" value="32.6" lower_limit="23.4" upper_limit="43.0"/>
                    <measurement group_id="O3" value="18.4" lower_limit="8.8" upper_limit="32.0"/>
                    <measurement group_id="O4" value="13.6" lower_limit="7.0" upper_limit="23.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vomiting (n= 48,79,43,76)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.3" lower_limit="2.3" upper_limit="20.0"/>
                    <measurement group_id="O2" value="1.3" lower_limit="0.0" upper_limit="6.9"/>
                    <measurement group_id="O3" value="4.7" lower_limit="0.6" upper_limit="15.8"/>
                    <measurement group_id="O4" value="3.9" lower_limit="0.8" upper_limit="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased appetite (n= 52,93,54,89)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.2" lower_limit="11.1" upper_limit="34.7"/>
                    <measurement group_id="O2" value="23.7" lower_limit="15.5" upper_limit="33.6"/>
                    <measurement group_id="O3" value="31.5" lower_limit="19.5" upper_limit="45.6"/>
                    <measurement group_id="O4" value="24.7" lower_limit="16.2" upper_limit="35.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New generalized muscle pain (n= 60,136,66,128)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.0" lower_limit="41.6" upper_limit="67.9"/>
                    <measurement group_id="O2" value="67.6" lower_limit="59.1" upper_limit="75.4"/>
                    <measurement group_id="O3" value="65.2" lower_limit="52.4" upper_limit="76.5"/>
                    <measurement group_id="O4" value="69.5" lower_limit="60.8" upper_limit="77.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aggravated generalized muscle pain(n=51,101,58,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.5" lower_limit="15.9" upper_limit="41.7"/>
                    <measurement group_id="O2" value="39.6" lower_limit="30.0" upper_limit="49.8"/>
                    <measurement group_id="O3" value="41.4" lower_limit="28.6" upper_limit="55.1"/>
                    <measurement group_id="O4" value="34.7" lower_limit="25.3" upper_limit="45.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New generalized joint pain (n= 53,91,53,93)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.9" lower_limit="9.4" upper_limit="32.0"/>
                    <measurement group_id="O2" value="23.1" lower_limit="14.9" upper_limit="33.1"/>
                    <measurement group_id="O3" value="24.5" lower_limit="13.8" upper_limit="38.3"/>
                    <measurement group_id="O4" value="33.3" lower_limit="23.9" upper_limit="43.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aggravated generalized joint pain (n= 51,91,49,88)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7" lower_limit="5.7" upper_limit="26.3"/>
                    <measurement group_id="O2" value="17.6" lower_limit="10.4" upper_limit="27.0"/>
                    <measurement group_id="O3" value="22.4" lower_limit="11.8" upper_limit="36.6"/>
                    <measurement group_id="O4" value="25.0" lower_limit="16.4" upper_limit="35.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events collected after vaccination and at the 6-month follow-up contact. Participants recorded pre-specified AEs in electronic diary: local reactions and systemic events from Day 1-Day 14 post vaccination.</time_frame>
      <desc>SAEs and AEs were grouped by system organ class and summarized. AEs included solicited AEs collected in the electronic diary (local and systemic reactions; systematic assessment) and unsolicited events collected on the case report form at each visit (nonsystematic assessment).</desc>
      <group_list>
        <group group_id="E1">
          <title>13vPnC, Cohort 1</title>
          <description>Participants aged 60-64 years old received 13 valent pneumococcal conjugate (13vPnC) administered as a single dose 0.5 mL (Vaccination 1 [Vax1]), reported after vaccination.</description>
        </group>
        <group group_id="E2">
          <title>13vPnC: 6 Month Follow-up After Vax 1, Cohort 1</title>
          <description>Participants aged 60-64 years old received 13 valent pneumococcal conjugate (13vPnC) administered as a single dose 0.5 mL (Vaccination 1), reported at 6-month follow-up.</description>
        </group>
        <group group_id="E3">
          <title>23vPS, Cohort 1</title>
          <description>Participants aged 60-64 years old received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a single dose 0.5 mL (Vaccination 1), reported after vaccination 1.</description>
        </group>
        <group group_id="E4">
          <title>23vPS: 6 Month Follow-up After Vax 1, Cohort 1</title>
          <description>Participants aged 60-64 years old received 23-valent pneumococcal polysaccharide vaccine (23vPS) administered as a single dose 0.5 mL (Vaccination 1), reported at 6-month follow-up.</description>
        </group>
        <group group_id="E5">
          <title>13vPnC, Cohort 2</title>
          <description>Participants aged 50-59 years old received 13vPnC administered as a single dose 0.5 mL (Vaccination 1), reported after vaccination 1. Out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence safety data is available for 403 participant.</description>
        </group>
        <group group_id="E6">
          <title>13vPnC: 6 Month Follow-up After Vax 1, Cohort 2</title>
          <description>Participants aged 50-59 years old received 13vPnC administered as a single dose 0.5 mL (Vaccination 1), reported at 6-month follow-up. Out of 404 participants vaccinated, 1 participant randomized and vaccinated in error without a consent form, and hence safety data is available for 403 participant.</description>
        </group>
        <group group_id="E7">
          <title>13vPnC/13vPnC, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 13vPnC at Year 3 to 4 (Vaccination 2), reported after vaccination 2.</description>
        </group>
        <group group_id="E8">
          <title>13vPnC/13vPnC: 6 Month Follow-up After Vax 2, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 13vPnC at Year 3 to 4 (Vaccination 2), reported at 6-month follow-up after vaccination 2.</description>
        </group>
        <group group_id="E9">
          <title>13vPnC/23vPS, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 23vPS at Year 3 to 4 (Vaccination 2), reported after vaccination 2.</description>
        </group>
        <group group_id="E10">
          <title>13vPnC/23vPS: 6 Month Follow-up After Vax 2, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 23vPS at Year 3 to 4 (Vaccination 2), reported at 6-month follow-up after vaccination 2.</description>
        </group>
        <group group_id="E11">
          <title>23vPS/23vPS, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 23vPS at vaccination 1 received a 0.5 mL single dose of open-label 23vPS at Year 3 to 4 (Vaccination 2), reported after vaccination 2.</description>
        </group>
        <group group_id="E12">
          <title>23vPS/23vPS: 6 Month Follow-up After Vax 2, Cohort 1</title>
          <description>Participants aged 60-64 years old who received 23vPS at vaccination 1 received a 0.5 mL single dose of open-label 23vPS at Year 3 to 4 (Vaccination 2), reported at 6-month follow-up after vaccination 2.</description>
        </group>
        <group group_id="E13">
          <title>13vPnC/13vPnC, Cohort 2</title>
          <description>Participants aged 50-59 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 13vPnC at Year 3 to 4 (Vaccination 2), reported after vaccination 2.</description>
        </group>
        <group group_id="E14">
          <title>13vPnC/13vPnC: 6 Month Follow-up After Vax 2, Cohort 2</title>
          <description>Participants aged 50-59 years old who received 13vPnC at vaccination 1 received a 0.5 mL single dose of open-label 13vPnC at Year 3 to 4 (Vaccination 2), reported at 6-month follow-up after vaccination 2.</description>
        </group>
        <group group_id="E15">
          <title>13vPnC, Cohort 3</title>
          <description>Participants aged 18-49 years old received 13vPnC administered as a single dose 0.5 mL (Vaccination 1), reported after vaccination 1.</description>
        </group>
        <group group_id="E16">
          <title>13vPnC: 6 Month Follow-up After Vax 1, Cohort 3</title>
          <description>Participants aged 18-49 years old received 13vPnC administered as a single dose 0.5 mL (Vaccination 1), reported at 6-month follow-up.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Endometrial cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Ovarian cyst ruptured</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Lymphadenectomy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="277" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="271" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="293" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="66" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="272" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="143" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="13" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="164" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="779" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lymph node pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness bilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ear congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ear discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Cerumen impaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Eye pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="12" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Chapped lips</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title vocab="Systemic Events">Fever Any (&gt;=38 degrees C)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="181"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="11" subjects_at_risk="185"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="137"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="79"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="16" subjects_at_risk="221"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever Mild (&gt;=38 degrees C but &lt;38.5 degrees C)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="180"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="137"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="79"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="9" subjects_at_risk="214"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever Moderate (&gt;=38.5 degrees C but &lt;39 degrees C)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="136"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="211"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever Severe (&gt;=39 degrees C but &lt;=40 degrees C)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="136"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="210"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever Potentially life threatening (&gt;40 degrees C)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>All reports of fever &gt;40 degrees C in 13vPnC and 23vPS for Cohort 1 were confirmed as data entry errors.</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="184"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="136"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="208"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fatigue</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="175" subjects_at_risk="277"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="168" subjects_at_risk="273"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="157" subjects_at_risk="248"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="35" subjects_at_risk="69"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="43" subjects_at_risk="68"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="72" subjects_at_risk="125"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="76" subjects_at_risk="125"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="446" subjects_at_risk="554"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Headache</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="252"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="141" subjects_at_risk="259"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="162" subjects_at_risk="246"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="23" subjects_at_risk="60"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="32" subjects_at_risk="64"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="64" subjects_at_risk="118"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="76" subjects_at_risk="123"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="429" subjects_at_risk="527"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Chills</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="204"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="199"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="31" subjects_at_risk="158"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="52"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="19" subjects_at_risk="56"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="34" subjects_at_risk="99"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="24" subjects_at_risk="93"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="109" subjects_at_risk="286"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Rash</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="194"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="192"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="148"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="51"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="9" subjects_at_risk="49"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="31" subjects_at_risk="95"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="81"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="53" subjects_at_risk="249"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Vomiting</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="144"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="43"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="79"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="76"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="36" subjects_at_risk="240"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased appetite</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="202"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="45" subjects_at_risk="207"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="42" subjects_at_risk="166"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="52"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="17" subjects_at_risk="54"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="22" subjects_at_risk="93"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="22" subjects_at_risk="89"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="202" subjects_at_risk="363"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">New generalized muscle pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="140" subjects_at_risk="249"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="155" subjects_at_risk="268"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="147" subjects_at_risk="238"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="33" subjects_at_risk="60"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="43" subjects_at_risk="66"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="92" subjects_at_risk="136"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="89" subjects_at_risk="128"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="460" subjects_at_risk="561"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Aggravated generalized muscle pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="215"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="84" subjects_at_risk="225"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="75" subjects_at_risk="188"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="14" subjects_at_risk="51"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="24" subjects_at_risk="58"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="40" subjects_at_risk="101"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="33" subjects_at_risk="95"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="207" subjects_at_risk="370"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">New generalized joint pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="197"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="65" subjects_at_risk="216"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="52" subjects_at_risk="165"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="53"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="13" subjects_at_risk="53"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="21" subjects_at_risk="91"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="31" subjects_at_risk="93"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="128" subjects_at_risk="307"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Aggravated generalized joint pain</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="205"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="44" subjects_at_risk="206"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="43" subjects_at_risk="168"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="51"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="16" subjects_at_risk="91"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="22" subjects_at_risk="88"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="77" subjects_at_risk="269"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Axillary pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injury associated with device</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vessel puncture site haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site pallor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site warmth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Allergy to vaccine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="11" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="7" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gingival infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Skin candida</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Tinea infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Procedural dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Skin injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Polydipsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Muscle tightness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Medial tibial stress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Aphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Generalised anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Depressive symptom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Atrophic vulvovaginitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Testicular pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nipple exudate bloody</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Atrophic vulvovaginitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Diaphragmalgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Paranasal sinus hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Pulmonary congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Upper-airway cough syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title vocab="Local Reactions">Redness (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="193"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="190"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="152"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="14" subjects_at_risk="51"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="39" subjects_at_risk="109"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="18" subjects_at_risk="84"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="81" subjects_at_risk="266"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Redness (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="189"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="187"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="151"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="28" subjects_at_risk="101"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="15" subjects_at_risk="83"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="68" subjects_at_risk="258"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Redness (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="185"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="182"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="140"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="44"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="17" subjects_at_risk="91"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="27" subjects_at_risk="227"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Redness (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="137"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="85"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="6" subjects_at_risk="211"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Swelling (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="197"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="25" subjects_at_risk="191"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="35" subjects_at_risk="161"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="53"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="37" subjects_at_risk="104"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="84"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="119" subjects_at_risk="302"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Swelling (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="192"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="19" subjects_at_risk="189"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="33" subjects_at_risk="160"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="52"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="9" subjects_at_risk="48"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="19" subjects_at_risk="91"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="18" subjects_at_risk="84"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="109" subjects_at_risk="293"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Swelling (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="184"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="138"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="23" subjects_at_risk="95"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="36" subjects_at_risk="238"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Swelling (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="180"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="136"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="42"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="82"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="209"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Pain (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="265" subjects_at_risk="331"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="221" subjects_at_risk="301"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="286" subjects_at_risk="322"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="62" subjects_at_risk="79"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="73" subjects_at_risk="87"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="139" subjects_at_risk="164"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="161" subjects_at_risk="173"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="761" subjects_at_risk="787"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Pain (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="254" subjects_at_risk="323"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="199" subjects_at_risk="290"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="263" subjects_at_risk="306"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="58" subjects_at_risk="76"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="68" subjects_at_risk="83"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="125" subjects_at_risk="156"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="150" subjects_at_risk="165"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="672" subjects_at_risk="721"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Pain (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="206"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="63" subjects_at_risk="210"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="75" subjects_at_risk="190"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="53"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="26" subjects_at_risk="59"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="57" subjects_at_risk="111"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="60" subjects_at_risk="112"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="360" subjects_at_risk="467"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Pain (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="16" subjects_at_risk="187"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="139"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="4" subjects_at_risk="44"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="86"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="38" subjects_at_risk="238"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Limitation of arm movement (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="214"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="65" subjects_at_risk="211"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="79" subjects_at_risk="194"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="15" subjects_at_risk="54"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="24" subjects_at_risk="57"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="54" subjects_at_risk="112"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="56" subjects_at_risk="109"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="375" subjects_at_risk="499"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Limitation of arm movement (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="212"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="61" subjects_at_risk="208"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="73" subjects_at_risk="189"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="54"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="23" subjects_at_risk="57"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="51" subjects_at_risk="110"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="51" subjects_at_risk="106"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="333" subjects_at_risk="466"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Limitation of arm movement (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="182"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="140"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="43"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="81"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="7" subjects_at_risk="77"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="44" subjects_at_risk="238"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title vocab="Local Reactions">Limitation of arm movement (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="180"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="185"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="139"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="41"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="84"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="77"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E15" subjects_affected="37" subjects_at_risk="237"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rosacea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Precancerous skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Erythema multiforme</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Venous insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>Hot flush</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
              <event>
                <sub_title>hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="417"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="417"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="414"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="403"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="108"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="189"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="214"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="899"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="899"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

